Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$0.2 - $0.61 $2,311 - $7,050
-11,558 Reduced 8.33%
127,174 $27,000
Q1 2022

May 13, 2022

BUY
$0.48 - $0.74 $42,931 - $66,186
89,441 Added 181.46%
138,732 $86,000
Q4 2021

Feb 14, 2022

BUY
$0.7 - $1.94 $18,498 - $51,266
26,426 Added 115.57%
49,291 $34,000
Q3 2021

Nov 08, 2021

BUY
$1.82 - $5.71 $6,137 - $19,254
3,372 Added 17.3%
22,865 $41,000
Q2 2021

Aug 11, 2021

SELL
$5.22 - $7.33 $720 - $1,011
-138 Reduced 0.7%
19,493 $113,000
Q1 2021

May 14, 2021

BUY
$4.0 - $10.28 $27,928 - $71,774
6,982 Added 55.2%
19,631 $127,000
Q4 2020

Feb 10, 2021

BUY
$2.43 - $4.68 $30,737 - $59,197
12,649 New
12,649 $46,000

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.